Telomere, aging and age-related diseases

Aging Clinical and Experimental Research

Volumn 25, Issue 2, 2013, Pages 139-146

  Xi, Huanjiu ^a   Li, Changyong ^b   Ren, Fu ^a   Zhang, Hailong ^a   Zhang, Luping ^c  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Age related diseases; Aging; Cell senescence; Telomerase; Telomere

Indexed keywords

TELOMERASE;

AGE RELATED DISEASE; AGING; CARDIOVASCULAR DISEASE; CHROMOSOME; DIABETES MELLITUS; DISEASES; DNA DAMAGE; DYSKERATOSIS CONGENITA; HUMAN; IMMUNOPATHOLOGY; NEOPLASM; REVIEW; SENESCENCE; TELOMERE; TELOMERE SHORTENING;

AGING; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; NEOPLASMS; TELOMERE HOMEOSTASIS;

EID: 84886690686     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0021-1     Document Type: Review

References (89)

1. Reaper PM, di Fagagna FD, Jackson SP (2004) Activation of the DNA damage response by telomere attrition - a passage to cellular senescence. Cell Cycle 3:543-546
2. Shammas MA (2011) Telomeres, lifestyle, cancer, and aging. Current Opinion Clin Nutr Metab Care 14:28-34
3. Takubo K, Aida J, Izumiyama-Shimomura N, Ishikawa N, Sawabe M, Kurabayashi R, Shiraishi H et al (2010) Changes of telomere length with aging. Geriatr Gerontol Int 10:S197-S206
4. Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev 88:557-579
5. Wong LSM, van der Harst P, de Boer RA, Huzen J, van Gilst WH, van Veldhuisen DJ (2010) Aging, telomeres and heart failure. Heart Fail Rev 15:479-486
6. Huzen J, de Boer RA, van Veldhuisen DJ, van Gilst WH, van der Harst P (2010) The emerging role of telomere biology in cardiovascular disease. Frontiers Biosci Landmark 15:35-45
7. Oeseburg H, de Boer RA, van Gilst WH, van der Harst P (2010) Telomere biology in healthy aging and disease. Pflugers Arch 459:259-268
8. Lin KW, Yan J (2005) The telomere length dynamic and methods of its assessment. J Cell Mol Med 9:977-989
9. Zakian VA (1996) Structure, function, and replication of Saccharomyces cerevisiae telomeres. Annu Rev Genet 30:141-172
10. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T (1999) Mammalian telomeres end in a large duplex loop. Cell 97:503-514
11. Stewart JA, Chaiken MF, Wang F, Price CM (2012) Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat Res 730:12-19
12. Broccoli D, Smogorzewska A, Chong L, de Lange T (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17:231-235
13. Kim SH, Kaminker P, Campisi J (1999) TIN2, a new regulator of telomere length in human cells. Nat Genet 23:405-412
14. McKerlie MA, Lin S, Zhu XD (2012) ATM regulates proteasome-dependent subnuclear localization of TRF1, which is important for telomere maintenance. Nucleic Acids Res 40:3975-3989
15. Mason M, Schuller A, Skordalakes E (2011) Telomerase structure function. Curr Opin Struct Biol 21:92-100
16. Artandi SE, DePinho RA (2010) Telomeres and telomerase in cancer. Carcinogenesis 31:9-18
17. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, Roos G (1997) Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 57:549-554
18. Halvorsen TL, Leibowitz G, Levine F (1999) Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 19:1864-1870
19. Shay JW, Wright WE (2005) Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26:867-874
20. Lanza RP, Cibelli JB, Blackwell C, Cristofalo VJ, Francis MK, Baerlocher GM, Mak J et al (2000) Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 288:665-669
21. Lansdorp PM (2000) Repair of telomeric DNA prior to replicative senescence. Mech Ageing Dev 118:23-34
22. Martinez P, Blasco MA (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11:161-176
23. Diaz VA, Mainous AG 3rd, Everett CJ, Schoepf UJ, Codd V, Samani NJ (2010) Effect of healthy lifestyle behaviors on the association between leukocyte telomere length and coronary artery calcium. Am J Cardiol 106:659-663
24. Cassidy A, De Vivo I, Liu Y, Han J, Prescott J, Hunter DJ, Rimm EB (2010) Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr 91:1273-1280
25. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ et al (2008) Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 9:1048-1057
26. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW et al (1992) Telomere Length Predicts Replicative Capacity of Human Fibroblasts. Proc Natl Acad Sci USA 89:10114-10118
27. Greenberg RA (2005) Telomeres, crisis and cancer. Curr Mol Med 5:213-218
28. di Fagagna FD, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T, Saretzki G et al (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-198
29. Karlseder J, Broccoli D, Dai YM, Hardy S, de Lange T (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-1325
30. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW (1996) Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 15:1734-1741
31. Allsopp RC, Harley CB (1995) Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219:130-136
32. Huang XQ, Wang J, Liu JP, Feng H, Liu WB, Yan Q, Liu Y et al (2005) hTERT extends proliferative lifespan and prevents oxidative stress-induced apoptosis in human lens epithelial cells. Invest Ophthalmol Vis Sci 46:2503-2513
33. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352
34. Wieser M, Stadler G, Jennings P, Streubel B, Pfaller W, Ambros P, Riedl C et al (2008) hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 295:F1365-F1375
35. Njajou OT, Hsueh WC, Blackburn EH, Newman AB, Wu SH, Li RL, Simonsick EM et al (2009) Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol Ser A Biol Sci Med Sci 64:860-864
36. Hunt SC, Chen W, Gardner JP, Kimura M, Srinivasan SR, Eckfeldt JH, Berenson GS et al (2008) Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell 7:451-458
37. Ren F, Li CY, Xi HJ, Wen YF, Huang KQ (2009) Estimation of human age according to telomere shortening in peripheral blood leukocytes of Tibetan. Am J Forensic Med Pathol 30:252-255
38. Vaziri H, Schachter F, Uchida I, Wei L, Zhu XM, Effros R, Cohen D et al (1993) Loss of telomeric DNA during aging of normal and trisomy-21 human-lymphocytes. Am J Hum Genet 52:661-667
39. Andrews NP, Fujii H, Goronzy JJ, Weyand CM (2010) Telomeres and immunological diseases of aging. Gerontology 56:390-403
40. von Zglinicki T, Martin-Ruiz CM (2005) Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 5:197-203
41. Harley CB (2005) Telomerase therapeutics for degenerative diseases. Curr Mol Med 5:205-211
42. Asselbergs FW, van der Harst P, Jessurun GAJ, Tio RA, van Gilst WH (2005) Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins. Vascul Pharmacol 42:125-140
43. Mainous AG, Diaz VA (2010) Telomere length as a risk marker for cardiovascular disease: the next big thing? Expert Rev Mol Diagn 10:969-971
44. De Meyer T, Rietzschel ER, De Buyzere ML, Van Criekinge W, Bekaert S (2011) Telomere length and cardiovascular aging: the means to the ends? Ageing Res Rev 10:297-303
45. Chang E, Harley CB (1995) Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92:11190-11194
46. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I (2002) Endothelial cell senescence in human atherosclerosis - role of telomere in endothelial dysfunction. Circulation 105:1541-1544
47. Fenton M, Barker S, Kurz DJ, Erusalimsky JD (2001) Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler Thromb Vasc Biol 21:220-226
48. Yang ZW, Huang X, Jiang H, Zhang YR, Liu HX, Qin C, Eisner GM et al (2009) Short telomeres and prognosis of hypertension in a chinese population. Hypertension 53:639-695
49. Imanishi T, Moriwaki C, Hano T, Nishio I (2005) Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 23:1831-1837
50. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B et al (2003) Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 22:131-139
51. Wong LSM, de Boer RA, Samani NJ, van Veldhuisen DJ, Harst PD (2008) Telomere biology in heart failure. Eur J Heart Fail 10:1049-1056
52. van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH et al (2007) Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 49:1459-1464
53. Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B, Leri A et al (2003) Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 100:10440-10445
54. Oh H, Wang SC, Prahash A, Sano M, Moravec CS, Taffett GE, Michael LH et al (2003) Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci USA 100:5378-5383
55. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F et al (2003) Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 93:604-613
56. Zee RYL, Castonguay AJ, Barton NS, Germer S, Martin M (2010) Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Transl Res 155:166-169
57. Salpea KD, Talmud PJ, Cooper JA, Maubaret CG, Stephens JW, Abelak K, Humphries SE (2010) Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209:42-50
58. Fyhrquist F, Tiitu A, Saijonmaa O, Forsblom C, Groop PH (2010) Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. J Intern Med 267:278-286
59. Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P et al (2010) Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia 53:45-48
60. Kuhlow D, Florian S, von Figura G, Weimer S, Schulz N, Petzke KJ, Zarse K et al (2010) Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging (US) 2:650-658
61. Adaikalakoteswari A, Balasubramanyam M, Ravikumar R, Deepa R, Mohan V (2007) Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis 195:83-89
62. Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A, Kimura M et al (2006) Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 5:325-330
63. Hahn WC (2003) Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21:2034-2043
64. Chung HK, Cheong C, Song J, Lee HW (2005) Extratelomeric functions of telomerase. Curr Mol Med 5:233-241
65. Wu XF, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S et al (2003) Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 95:1211-1218
66. Mu YC, Zhang Q, Mei LH, Liu XS, Yang WL, Yu JR (2011) Telomere shortening occurs early during gastrocarcinogenesis. Med Oncol. doi: 10.1007/s12032-011- 9866-3
67. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL et al (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5:1164-1170
68. Guittat L, Alberti P, Mergny JL, Riou JF, Teulade-Fichou MP, Mailliet P (2001) Telomerase inhibitors: possible consequences in cancer therapy. M S-Med Sci 17:1076-1081
69. Perry PJ, Arnold JRP, Jenkins TC (2001) Telomerase inhibitors for the treatment of cancer: the current perspective. Expert Opin Investig Drugs 10:2141-2156
70. Hashizume R, Gupta N (2010) Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery. Curr Opin Mol Ther 12:168-175
71. Agrawal A, Dang S, Gabrani R (2012) Recent patents on anti-telomerase cancer therapy. Recent Pat Anticancer Drug Discov 7:102-117
72. Malavolta M, Mocchegiani E, Bertoni-Freddari C (2004) New trends in biomedical aging research. Gerontology 50:420-424
73. Goronzy JJ, Fujii H, Weyand CM (2006) Telomeres, immune aging and autoimmunity. Exp Gerontol 41:246-251
74. Effros RB (2003) Genetic alterations in the ageing immune system: impact on infection and cancer. Mech Ageing Dev 124:71-77
75. Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet AS, Hermine O (2010) The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev 9:646-651
76. Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, Wikby A (2004) Is immunosenescence infectious? Trends Immunol 25:406-410
77. Akbar AN, Beverley PCL, Salmon M (2004) Opinion: will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol 4:737-743
78. Effros RB, Boucher N, Porter V, Zhu XM, Spaulding C, Walford RL, Kronenberg M et al (1994) Decline in Cd28(+) T-cells in centenarians and in long-term t-cell cultures - a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 29:601-609
79. Weng NP, Levine BL, June CH, Hodes RJ (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183:2471-2479
80. Spaulding C, Guo W, Effros RB (1999) Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 34:633-644
81. Weng NP (2001) Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol 70:861-867
82. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361:393-395
83. Mitchell JR, Wood E, Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551-555
84. Mason PJ, Wilson DB, Bessler M (2005) Dyskeratosis congenita - a disease of dysfunctional telomere maintenance. Curr Mol Med 5:159-170
85. Walne AJ, Marrone A, Dokal I (2005) Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol 82:184-189
86. Bessler M, Wilson DB, Mason PJ (2004) Dyskeratosis congenita and telomerase. Curr Opin Pediatr 16:23-28
87. Mather KA, Jorm AF, Parslow RA, Christensen H (2011) Is telomere length a biomarker of aging? A review. J Gerontol Ser A Biol Sci Med Sci 66:202-213
88. Cong YS, Shay JW (2008) Actions of human telomerase beyond telomeres. Cell Res 18:725-732
89. Egan CA, Savre-Train I, Shay JW, Wilson SE, Bourne WM (1998) Analysis of telomere lengths in human corneal endothelial cells from donors of different ages. Invest Ophthalmol Vis Sci 39:648-653